Evommune Ownership | Who Owns Evommune?
Evommune Ownership Summary
Evommune is owned by 109.00% institutional investors, 7.98% insiders. Eqt fund management s.a r.l. is the largest institutional shareholder, holding 15.64% of EVMN shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 3.36% of its assets in Evommune shares.
EVMN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Evommune | 109.00% | 7.98% | -16.98% |
| Sector | Healthcare Stocks | 50.44% | 12.38% | 37.18% |
| Industry | Biotech Stocks | 48.97% | 12.07% | 38.96% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Eqt fund management s.a r.l. | 4.93M | 15.64% | $113.33M |
| Ra capital management | 3.49M | 11.09% | $80.34M |
| Pivotal bioventure partners investment advisor | 1.93M | 6.11% | $44.30M |
| Andera partners | 1.90M | 6.02% | $43.62M |
| Rtw investments, lp | 1.50M | 4.77% | $34.54M |
| Jpmorgan chase | 1.46M | 4.63% | $32.11M |
| Nan fung group | 1.44M | 4.57% | $33.13M |
| Eventide asset management | 1.21M | 3.84% | $27.80M |
| Price t rowe associates inc /md/ | 1.12M | 3.55% | $25.73M |
| Janus henderson group | 896.70K | 2.84% | $20.62M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Nan fung group | 1.44M | 27.32% | $33.13M |
| Andera partners | 1.90M | 24.66% | $43.62M |
| Pivotal bioventure partners investment advisor | 1.93M | 15.83% | $44.30M |
| Eqt fund management s.a r.l. | 4.93M | 11.10% | $113.33M |
| Velan capital investment management lp | 446.25K | 6.43% | $10.26M |
| Great point partners | 325.00K | 1.72% | $7.47M |
| Ra capital management | 3.49M | 0.85% | $80.34M |
| Blue owl capital lp | 100.00K | 0.62% | $2.30M |
| Eventide asset management | 1.21M | 0.46% | $27.80M |
| Rtw investments, lp | 1.50M | 0.34% | $34.54M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 896.70K | 0.01% | 896.70K |
| Baker bros. advisors lp | 847.39K | 0.11% | 847.39K |
| Alyeska investment group | 726.36K | 0.05% | 726.36K |
| Blackrock funding, inc. /de | 673.57K | 0.00% | 531.13K |
| Freestone grove partners lp | 337.29K | 0.05% | 337.29K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bioimpact capital | - | - | -1.46M |
| Marshall wace, llp | - | - | -879.73K |
| Kynam capital management, lp | - | - | -625.50K |
| Sectoral asset management | - | - | -589.00K |
| Abrdn | - | - | -525.38K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Janus henderson group | 896.70K | 0.01% | 896.70K | $20.62M |
| Baker bros. advisors lp | 847.39K | 0.11% | 847.39K | $19.48M |
| Alyeska investment group | 726.36K | 0.05% | 726.36K | $16.70M |
| Freestone grove partners lp | 337.29K | 0.05% | 337.29K | $7.75M |
| Blue owl capital lp | 100.00K | 0.62% | 100.00K | $2.30M |
Sold Out
| Holder | Change |
|---|---|
| Royal bank of canada | -585.00 |
| Plante moran financial advisors | -1.15K |
| Strs ohio | -1.80K |
| National bank of canada /fi/ | -2.40K |
| China universal asset management | -5.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 81 | 37.29% | 34,361,905 | 26.33% | 109 | 1.46% | 61 | 3.39% | 11 | - |
| Dec 31, 2025 | 59 | - | 27,200,904 | - | 86 | - | 59 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Eventide Healthcare & Life Sciences I | 1.21M | 3.36% | 247.60K |
| Vanguard Morn Total Stk Mkt Idx Investor | 739.07K | 2.05% | 452.27K |
| Vanguard Total Stock Mkt Idx Inv | 739.07K | 2.05% | 452.27K |
| T. Rowe Price New Horizons | 614.72K | 1.71% | 100.00K |
| US Small-Cap Growth II Equity Comp | 614.72K | 1.71% | 251.99K |
| American Century Small Cap Growth Inv | 567.83K | 1.58% | 190.57K |
| American Century U.S. Small Cap Growth | 567.83K | 1.58% | 190.57K |
| JPMorgan Small Cap Growth A | 554.36K | 1.54% | -46.78K |
| JPM Global Healthcare C acc USD | 359.29K | 1.00% | -9.85K |
| Federated Hermes Kaufmann Small Cap Grow | 325.00K | 0.90% | - |
EVMN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools